Although the clinical features of the present case are the long duration of response, complete remission of metastatic sites with chemotherapy, and repeated local regrowth of the primary lung cancer, the effective treatments against ALK‐ rearranged lung cancer might eradicate most of cancer cells but fails to destroy drug‐resistant cancer cells. This evidence concerns the gene ALK and lung carcinoma.